LDL cholesterol performance of beta quantification reference measurement procedure

Castelli, 1984, Epidemiology of coronary heart disease: the Framingham study, Am J Med, 27, 4, 10.1016/0002-9343(84)90952-5 Castelli, 1996, Lipids, risk factors and ischaemic heart disease, Atherosclerosis, 124 Teramoto, 2007, Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese, J Atheroscler Thromb, 14, 267, 10.5551/jat.E578 Teramoto, 2008, Primary hyperlipidemia, committee for epidemiology and clinical management of atherosclerosis, J Atheroscler Thromb, 15, 49, 10.5551/jat.E590 1984, The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 251, 365, 10.1001/jama.1984.03340270043026 Grundy, 1988, HMG-CoA reductase inhibitors for treatment of hypercholesterolemia, N Engl J Med, 319, 24, 10.1056/NEJM198807073190105 Teramoto, 2010, Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate hypercholesterolemic Japanese, J Atheroscler Thromb, 17, 879, 10.5551/jat.4176 Imano, 2011, Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS), Prev Med, 52, 381, 10.1016/j.ypmed.2011.02.019 Stone, 2013, ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines, J Am Coll Cardiol, 62, 1 2001, National Cholesterol Education Program: executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Warnick, 2002, Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory, Clin Chem, 48, 11, 10.1093/clinchem/48.1.11 2012, European guidelines on cardiovascular disease prevention in clinical practice (version 2012), Eur Heart J, 33, 1635, 10.1093/eurheartj/ehs092 Japan Atherosclerosis Society, 2012 1995 Hainline, 1982 Bachorik, 1995, National Cholesterol Education Program Recommendations for measurement of low-density lipoprotein cholesterol: executive summary, Clin Chem, 41, 1414, 10.1093/clinchem/41.10.1414 Bachorik, 2000, Measurement of low-density-lipoprotein cholesterol, 245 1991, 30333 Abell, 1952, A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity, J Biol Chem, 195, 357, 10.1016/S0021-9258(19)50907-3 1995, Method comparison and bias estimation using patient samples; approved guideline, Vol. 15 No.17 Westgard, 1973, Use and interpretation of common statistical tests in method-comparison studies, Clin Chem, 19, 49, 10.1093/clinchem/19.1.49 Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, 327, 307, 10.1016/S0140-6736(86)90837-8 Cole, 2001, Optimization of beta-quantification methods for high-throughput applications, Clin Chem, 47, 712, 10.1093/clinchem/47.4.712 Waymack, 2000, Accuracy and precision issues in modification of the serum volume requirement of the CDC beta quantification reference method for low-density lipoprotein cholesterol from 5ml to 2ml, Clin Chem, 46 Weykamp, 2008, The IFCC reference measurement system for HbA1c: a 6-year progress report, Clin Chem, 54, 240, 10.1373/clinchem.2007.097402 Waymack, 1998, Beta quantification round robin for low density lipoprotein cholesterol using frozen reference serum, Clin Chem, 44 Waymack, 2000, Use of frozen serum for accuracy transfer from CDC LDL-beta quantification reference method to three homogeneous LDL-cholesterol methods, Clin Chem, 46 Waymack, 1999, The effect of temperature on the beta quantification procedure for low-density lipoprotein cholesterol in serum, Clin Chem, 45 McNamara, 1995, Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated, Clin Chem, 41, 232, 10.1093/clinchem/41.2.232 Pisani, 1996, Performance of a direct LDL-cholesterol method compared to beta quantification, Pure Appl Chem, 68, 1887, 10.1351/pac199668101887 Nakamura, 2010, Ten-year evaluation of homogeneous low-density lipoprotein cholesterol methods developed by Japanese manufacturers—application of the Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network lipid standardization protocol, J Atheroscler Thromb, 17, 1275, 10.5551/jat.5470 Miller, 2010, Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures, Clin Chem, 56, 977, 10.1373/clinchem.2009.142810 Miida, 2012, A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects, Atherosclerosis, 225, 208, 10.1016/j.atherosclerosis.2012.08.022 Cole, 2013, Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC lipoprotein and vascular diseases division working group on best practices, Clin Chem, 59, 752, 10.1373/clinchem.2012.196733 Contois, 2011, Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement, J Clin Lipid, 5, 264, 10.1016/j.jacl.2011.05.004 Warnick, 2002, Lack of agreement of homogeneous assays with the reference method for LDL-cholesterol may not indicate unreliable prediction of risk for cardiovascular disease, Clin Chem, 48, 1812, 10.1093/clinchem/48.10.1812 Cole, 2013, Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices, Clin Chem, 59, 752, 10.1373/clinchem.2012.196733